This site is for US healthcare professionals only
Clinical diagnosis of CKD in a patient with T2D
Persistent change in either or both of the following for ≥3 months1
Elevated albuminuria1
UACR ≥30 mg/g
Marker of kidney damage2
Reduced eGFR1
<60 mL/min/1.73 m2
Measure of kidney function2
UACR testing in patients with T2D remains suboptimal3
≈50%
receive a UACR test
≈90%
receive an eGFR test
To improve patient care, both UACR and eGFR are necessary
Albuminuria is an early marker of kidney damage and cardiorenal risk4,5
Measuring eGFR alone may miss earlier stages of CKD4
Patients with normal eGFR are still at increased risk of CV events and CKD progression if albuminuria is present4
Want to see more?
Keep Exploring
CKD, chronic kidney disease; CV, cardiovascular; eGFR, estimated glomerular filtration rate; T2D, type 2 diabetes; UACR, urine albumin-to-creatinine ratio.
1. de Boer IH, et al. Diabetes Care. 2022;45(12):3075-3090. 2. Kidney Disease Improving Global Outcomes. Kidney Int Suppl. 2013;3(1):1-150. 3. Stempniewicz N, et al. Diabetes Care.2021;44(9):2000-2009. 4. American Diabetes Association. Section 11. Diabetes Care. 2024;47(Suppl 1):S219-S230. 5. Looker HC, et al. J Am Soc Nephrol. 2019;30:1049-1059.
You are encouraged to report side effects or quality complaints of products to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088. For Bayer products, you can report these directly to Bayer by clicking here.
